Paper42940171PubMed
Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells.
Zahedipour F and 9 others. Biomedicines, 2026.
Cite this record
ConductScience Library. Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells. Papers, record 42940171. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42940171
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells.
- Journal
- Biomedicines
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Förderverein und Stiftung für Krebskranke Kinder Tübingen e.V. | PubMed | |||
| University Children's Hospital Tübingen | PubMed | |||
| University of Tübingen | PubMed |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31951421 | Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering. | Nano Lett | 2020 | https://conductscience.org/library/papers/31951421 | PubMed |
| 2 | 33925968 | In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment. | Cells | 2021 | https://conductscience.org/library/papers/33925968 | PubMed |
| 3 | 27188790 | Glioma. | Nat Rev Dis Primers | 2015 | https://conductscience.org/library/papers/27188790 | PubMed |
| 4 | 39562005 | Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/39562005 | PubMed |
| 5 | 33959279 | CAR-NK cells: the next wave of cellular therapy for cancer. | Clin Transl Immunology | 2021 | https://conductscience.org/library/papers/33959279 | PubMed |
| 6 | 31675094 | CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. | Neuro Oncol | 2019 | https://conductscience.org/library/papers/31675094 | PubMed |
| 7 | 39962245 | Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. | Nat Mater | 2025 | https://conductscience.org/library/papers/39962245 | PubMed |
| 8 | 29972753 | Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29972753 | PubMed |
| 9 | 36361619 | Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36361619 | PubMed |
| 10 | 19544488 | B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction. | Eur J Immunol | 2009 | https://conductscience.org/library/papers/19544488 | PubMed |
| 11 | 22271890 | Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model. | Haematologica | 2012 | https://conductscience.org/library/papers/22271890 | PubMed |
| 12 | 28864289 | Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia. | Cytotherapy | 2017 | https://conductscience.org/library/papers/28864289 | PubMed |
| 13 | 34168003 | Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/34168003 | PubMed |
| 14 | 37443804 | Chimeric Antigen Receptor T Cells in Glioblastoma-Current Concepts and Promising Future. | Cells | 2023 | https://conductscience.org/library/papers/37443804 | PubMed |
| 15 | 34373623 | Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. | Nat Rev Immunol | 2021 | https://conductscience.org/library/papers/34373623 | PubMed |
| 16 | 40653819 | Lipid nanoparticle formulation for gene editing and RNA-based therapies for glioblastoma. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/40653819 | PubMed |
| 17 | 11224528 | B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. | Nat Immunol | 2001 | https://conductscience.org/library/papers/11224528 | PubMed |
| 18 | 34850635 | Chemistry of Lipid Nanoparticles for RNA Delivery. | Acc Chem Res | 2022 | https://conductscience.org/library/papers/34850635 | PubMed |
| 19 | 39761676 | mRNA-laden lipid nanoparticle-enabled humanized CD19 CAR-T-cell engineering for the eradication of leukaemic cells. | Br J Haematol | 2025 | https://conductscience.org/library/papers/39761676 | PubMed |
| 20 | 18690846 | The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion. | Curr Cancer Drug Targets | 2008 | https://conductscience.org/library/papers/18690846 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42940171
GET https://conductscience.org/api/papers/v1/42940171/references?page=2